Phase II study of bortezomib in Waldenstrom's Macroglobulinemia: Results of WMCTG trial 03-248. 47th Annual Meeting of the American-Society-of-Hematology Treon, S., Hunter, Z. R., Matous, J., Badros, A., Joyce, R. M., Mannion, B., Advani, R., Cook, D., Songer, J., Hill, J., Kaden, B. R., Sharon, D., Steiss, R., Branagan, A. R., Patterson, C. J. AMER SOC HEMATOLOGY. 2005: 147A–147A

View details for Web of Science ID 000233426000491